Mathematical modeling of preadipocyte fate determination

Journal of Theoretical Biology

Volumn 265, Issue 1, 2010, Pages 87-94

  Coskun, Huseyin ^a   Summerfield, Taryn L S ^a   Kniss, Douglas A ^a   Friedman, Avner ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Differentiation; NF B; PPAR ; Proliferation

Indexed keywords

I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

BIOLOGY; EXPERIMENTAL STUDY; FAT; FEEDBACK MECHANISM; LIPID; MOLECULAR ANALYSIS; NUMERICAL MODEL; PREDICTION; SIGNALING;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL FATE; CELL PROLIFERATION; FEEDBACK SYSTEM; IN VITRO STUDY; MATHEMATICAL MODEL; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROADIPOCYTE; STIMULUS;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; CELL LINEAGE; CULTURE MEDIA; MICE; MODELS, BIOLOGICAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77953604440     PISSN: 00225193     EISSN: 10958541     Source Type: Journal    
DOI: 10.1016/j.jtbi.2010.03.047     Document Type: Article

References (51)

1. Abella A., et al. Cdk4 promotes adipogenesis through pparg activation. Cell Metab. 2005, 2:239-249.
2. Ackerman W.E.I., Zhang X.L., Rovin B.H., Kniss D.A. Modulation of cytokine-induced cyclooxygenase 2 expression by pparg ligands through nfkappab signal disruption in human wish and amnion cells. Biol. Reprod. 2005, 73(3):527-535.
3. Ailhaud G., Grimaldi P., Negrel R. Cellular and molecular aspects of adipose tissue development. Ann. Rev. Nutr. 1992, 12:207-233.
4. Beg A.A. ComPPARtmentalizing NF-[kappa]B in the gut. Nat. Immunol. 2004, 5(1):14-16.
5. Beinke S., Ley S.C. Functions of nf-kappab1 and nf-kappab2 in immune cell biology. Biochem. J. 2004, 382(2):393-409.
6. Berg A.H., Lin Y., Lisanti M.P., Scherer P.E. Adipocyte differentiation induces dynamic changes in NF-kappaB expression and activity. Am. J. Physiol. Endocrinol. Metab. 2004, 287(6):E1178-E1188.
7. Bernlohr, D.A., Jenkins, A.E., Bennaars, A.A., 2004. Adipose tissue and lipid metabolism. Biochemistry of lipids, lipoproteins and membranes. In: Vance, D.E, Vancheri, C., Bernardi, G. (Eds.), New Comprehensive Biochemistry, fourth ed., vol. 36, Elsevier, Amsterdam, pp. 263-289.
8. Cawthorn W.P., Heyd F., Hegyi K., Sethi J.K. Tumour necrosis factor-[alpha] inhibits adipogenesis via a [beta]-catenin//tcf4(tcf7l2)-dependent pathway. Cell Death Differ. 2007, 14(7):1361-1373.
9. Cheong R., Levchenko A. Wires in the soup: quantitative models of cell signaling. Trends Cell Biol. 2008, 2008:112-118.
10. Chung S., LaPoint K., Martinez K., Kennedy A., Boysen Sandberg M., McIntosh M.K. Preadipocytes mediate lipopolysaccharide-induced inflammation and insulin resistance in primary cultures of newly differentiated human adipocytes. Endocrinology 2006, 147(11):5340-5351.
11. Chung S.W., Kang B.Y., Kim S.H., Pak Y.K., Cho D., Trinchieri G., Kim T.S. Oxidized low density lipoprotein inhibits interleukin-12 production in lipopolysaccharide-activated mouse macrophages via direct interactions between peroxisome proliferator-activated receptor-gamma and nuclear factor-kappa b. J. Biol. Chem. 2000, 275(42):32681-32687.
12. Clark R.B., Bishop-Bailey D., Estrada-Hernandez T., Hla T., Puddington L., Padula S.J. The nuclear receptor ppargamma and immunoregulation: Ppargamma mediates inhibition of helper t cell responses. J. Immunol. 2000, 164(3):1364-1371.
13. Farmer S.R. Transcriptional control of adipocyte formation. Cell Metab. 2006, 4(4):263-273.
14. Forman B.M., Tontonoz P., Chen J., Brun R.P., Spiegelman B.M., Evans R.M. 15-deoxy-[delta]12,14-prostaglandin j2 is a ligand for the adipocyte determination factor ppar[gamma]. Cell 1995, 83(5):803-812.
15. Fu M., Rao M., Bouras T., Wang C., Wu K., Zhang X., Li Z., Yao T.-P., Pestell R.G. Cyclin d1 inhibits peroxisome proliferator-activated receptor gamma-mediated adipogenesis through histone deacetylase recruitment. J. Biol. Chem. 2005, 280(17):16934-16941.
16. Ghosh S., Karin M. Missing pieces in the nf-kb puzzle. Cell 2002, 109:S81-S96.
17. Green H., Kehinde O. Sublines of mouse 3t3 cells that accumulate lipid. Cell 1974, 1:113-118.
18. Gregoire F.M. Adipocyte differentiation: from fibroblast to endocrine cell. Exp. Biol. Med. 2001, 226(11):997-1002.
19. Guo W., Zhang K.-M., Tu K., Li Y.-X., Zhu L., Xiao H.-S., Yang Y., Wu J.-R. Adipogenesis licensing and execution are disparately linked to cell proliferation. Cell Res. 2009, 19(2):216-223.
20. Hayes C.L., Ghosh S. Shared principles in nf-kb signaling. Cell 2008, 132:344-362.
21. Hoffmann A., Levchenko A., Scott M.L., Baltimore D. The ikappa b-nf-kappa b signaling module: temporal control and selective gene activation. Science 2002, 298(5596):1241-1245.
22. Hoshi S., Goto M., Koyama N., Nomoto K.-i., Tanaka H. Regulation of vascular smooth muscle cell proliferation by nuclear factor-kappa b and its inhibitor, i-kappa b. J. Biol. Chem. 2000, 275(2):883-889.
23. Hsieh T.-c., Wijeratne E.K., Liang J.-y., Gunatilaka A.L., Wu J.M. Differential control of growth, cell cycle progression, and expression of nf-[kappa]b in human breast cancer cells mcf-7, mcf-10a, and mda-mb-231 by ponicidin and oridonin, diterpenoids from the chinese herb rabdosia rubescens. Biochem. Biophys. Res. Commun. 2005, 337(1):224-231.
24. Jiang C., Ting A.T., Seed B. Ppar-[gamma] agonists inhibit production of monocyte inflammatory cytokines. Nature 1998, 391(6662):82-86.
25. Karin M., Lin A. Nf-kb at the crossroads of life and death. Nat. Immunol. 2002, 3(3):221-227.
26. Kikuchi A. Regulation of [beta]-catenin signaling in the wnt pathway. Biochem. Biophys. Res. Commun. 2000, 268(2):243-248.
27. Kim E.-K., Kwon K.-B., Koo B.-S., Han M.-J., Song M.-Y., Song E.-K., Han M.-K., Park J.-W., Ryu D.-G., Park B.-H. Activation of peroxisome proliferator-activated receptor-[gamma] protects pancreatic [beta]-cells from cytokine-induced cytotoxicity via nf[kappa]b pathway. Int. J. Biochem. Cell Biol. 2007, 39(6):1260-1275.
28. Klemm D.J., Leitner J.W., Watson P., Nesterova A., Reusch J.E.-B., Goalstone M.L., Draznin B. Insulin-induced adipocyte differentiation. activation of creb rescues adipogenesis from the arrest caused by inhibition of prenylation. J. Biol. Chem. 2001, 276(30):28430-28435.
29. Kniss D. Cyclooxygenases in reproductive medicine and biology. J. Soc. Gynecol. Invest. 1999, 6(6):285-292.
30. Kniss D.A., Rovin B., Fertel R.H., Zimmerman P.D. Blockade nf-[kappa]b activation prohibits tnf-[alpha]-induced cyclooxygenase-2 gene expression in ed27trophoblast-like cells. Placenta 2001, 22(1):80-89.
31. Lefterova M.I., Lazar M.A. New developments in adipogenesis. Trends Endocrinol. Metab. 2009, 20(3):107-114.
32. Lipniacki T. Mathematical model of nf-kb regulatory module. J. Theor. Biol. 2004, 228:195-215.
33. Miner J.L. The adipocyte as an endocrine cell. J. Animal Sci. 2004, 82:935-941.
34. Rangwala S.M., Lazar M.A. Transcriptional control of adipogenesis. Ann. Rev. Nutr. 2000, 20:535-559.
35. Ren H., Schmalstieg A., Yuan D., Gaynor R.B. I-kappab kinase beta is critical for b cell proliferation and antibody response. J. Immunol. 2002, 168(2):577-587.
36. Ricote M., Li A.C., Willson T.M., Kelly C.J., Glass C.K. The peroxisome proliferator-activated receptor-[gamma] is a negative regulator of macrophage activation. Nature 1998, 391(6662):79-82.
37. Rosen E.D., MacDonald O.A. Adipocyte differentiation from the inside out. Nat. Rev. Mol. Cell Biol. 2006, 7:885-896.
38. Rosen E.D., Spiegelman B.M. Molecular regulation of adipogenesis. Ann. Rev. Cell Dev. Biol. 2000, 16(1):145-171.
39. Rosen E.D., Hsu C.-H., Wang X., Sakai S., Freeman M.W., Gonzalez F.J., Spiegelman B.M. C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway. Genes Dev. 2002, 16(1):22-26.
40. Scherer P.E. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 2006, 55:1537-1545.
41. Setoguchi K., Misaki Y., Terauchi Y., Yamauchi T., Kawahata K., Kadowaki T., Yamamoto K. Peroxisome proliferator-activated receptor-γ haploinsufficiency enhances b cell proliferative responses and exacerbates experimentally induced arthritis. J. Clin. Invest. 2001, 108(11):1667-1675.
42. Shoelson S.E., Lee J., Goldfine A.B. Inflammation and insulin resistance. J. Clin. Invest. 2006, 116:1793-1801.
43. Tang Q.-Q., Otto T.C., Lane M.D. Ccaat/enhancer-binding protein b is required for mitotic clonal expansion during adipogenesis. Proc. Natl. Acad. Sci. 2003, 100(3):850-855.
44. Tang Q.-Q., Otto T.C., Lane M.D. Mitotic clonal expansion: a synchronous process required for adipogenesis. Proc. Natl. Acad. Sci. 2003, 100(1):44-49.
45. Ting A.Y., Endy D. Signal transduction: decoding nf-kb signaling. Science 2002, 298(5596):1189-1190.
46. Tontonoz P., Spiegelman B.M. Fat and beyond: the diverse biology of pparg. Ann. Rev. Biochem. 2008, 77:289-312.
47. Waki H., Tontonoz P. Endocrine functions of adipose tissue. Ann. Rev. Pathol. Mech. Dis. 2007, 2:31-56.
48. Wellen K.E., Hotamisligil G.S. Obesity-induced inflammatory changes in adipose tissue. J. Clin. Invest. 2003, 112(12):1785-1788.
49. Xie Y., Kang X., Ackerman W.E., Belury M.A., Koster C., Rovin B.H., Landon M.B., Kniss D.A. Differentiation-dependent regulation of the cyclooxygenase cascade during adipogenesis suggests a complex role for prostaglandins. Diabetes Obesity Metab. 2006, 8(1):83-93.
50. Yang X.Y., Wang L.H., Chen T., Hodge D.R., Resau J.H., DaSilva L., Farrar W.L. Activation of human t lymphocytes is inhibited by peroxisome proliferator-activated receptor gamma (ppargamma) agonists. ppargamma co-association with transcription factor nfat. J. Biol. Chem. 2000, 275(7):4541-4544.
51. Yuan M., et al. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of ikkb. Science 2001, 293:1673-1677.